ArticleOncoTargets and therapy2023

miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer [Retraction].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.